Bioceltix S.A. (BCX.WA)
PLN 79.8
(4.04%)
PLN 79.8
(4.04%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -9.13 Million PLN | -138.76% |
| 2022 | -3.82 Million PLN | 30.74% |
| 2021 | -5.52 Million PLN | -78.2% |
| 2020 | -3.09 Million PLN | -230.84% |
| 2019 | -936.98 Thousand PLN | 40.39% |
| 2018 | -1.57 Million PLN | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -6.72 Million PLN | 26.37% |
| 2024 Q2 | -19.82 Million PLN | -194.75% |
| 2023 FY | -9.13 Million PLN | -138.76% |
| 2023 Q1 | -1.79 Million PLN | 53.06% |
| 2023 Q4 | -9.13 Million PLN | 36.03% |
| 2023 Q3 | -14.27 Million PLN | 13.21% |
| 2023 Q2 | -16.45 Million PLN | -816.11% |
| 2022 Q4 | -3.82 Million PLN | -15.21% |
| 2022 Q2 | -2.33 Million PLN | 51.15% |
| 2022 Q1 | -4.77 Million PLN | 21.22% |
| 2022 Q3 | -3.32 Million PLN | -42.53% |
| 2021 Q3 | -6.59 Million PLN | 0.0% |
| 2021 Q4 | -6.05 Million PLN | 8.13% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BIOTON S.A. | 64.81 Million PLN | 114.095% |
| Captor Therapeutics Spolka Akcyjna | -71.92 Million PLN | 87.299% |
| Mabion S.A. | -11.98 Million PLN | 23.803% |
| Molecure S.A. | -56.84 Million PLN | 83.931% |
| NanoGroup S.A. | -537.61 Thousand PLN | -1599.223% |
| Pharmena S.A. | -22.05 Million PLN | 58.582% |
| Poltreg S.A. | -57.75 Million PLN | 84.183% |
| Pure Biologics Spólka Akcyjna | 9.33 Million PLN | 197.891% |
| Ryvu Therapeutics S.A. | -57.03 Million PLN | 83.983% |
| Synthaverse S.A. | 67.86 Million PLN | 113.46% |
| Urteste S.A. | -512 Thousand PLN | -1684.224% |